Literature DB >> 24258820

Smart drugs: Implications of student use.

R J Canterbury1, E Lloyd.   

Abstract

The use of Smart Drugs to enhance intelligence, improve memory and maximize cognitive functioning in healthy individuals has attracted the attention of the popular press. This paper discusses the implication of the nonmedical college student use of "nootropic" Smart Drugs, a class of pharmaceuticals legally available in other countries to treat diseases associated with mental decline or dysfunction. Nootropic drug use is compared to steroid use in a student population. In a survey of college students, 5% of the males reported casual use of a drug to increase their intelligence, enhance their memory and make them smarter: 2.5% of these students probably used a nootropic drug.

Entities:  

Year:  1994        PMID: 24258820     DOI: 10.1007/BF01324593

Source DB:  PubMed          Journal:  J Prim Prev        ISSN: 0278-095X


  20 in total

1.  AIDS panel calls for major effort on drug abuse and health care.

Authors:  Philip M Boffey
Journal:  N Y Times Web       Date:  1988-02-25

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?

Authors:  R T Bartus
Journal:  J Am Geriatr Soc       Date:  1990-06       Impact factor: 5.562

Review 4.  The development of behavioral tests to assess the effects of cognitive enhancers.

Authors:  D S Olton; L Wenk
Journal:  Pharmacopsychiatry       Date:  1990-02       Impact factor: 5.788

Review 5.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Clinical trials in memory disorders: objectives and methodology.

Authors:  A Alperovitch
Journal:  Arch Gerontol Geriatr Suppl       Date:  1989

7.  Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.

Authors:  B Saletu; J Grünberger; L Linzmayer
Journal:  Methods Find Exp Clin Pharmacol       Date:  1980-10

8.  The hypoxia model in human psychopharmacology: neurophysiological and psychometric studies with aniracetam i.v.

Authors:  B Saletu; J Grünberger
Journal:  Hum Neurobiol       Date:  1984

9.  Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  A clinical and neurophysiological trial on nootropic drugs in patients with mental decline.

Authors:  V Gallai; G Mazzotta; F Del Gatto; S Montesi; A Mazzetti; P Dominici; A Della Monica
Journal:  Acta Neurol (Napoli)       Date:  1991-02
View more
  1 in total

Review 1.  Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.

Authors:  Matěj Malík; Pavel Tlustoš
Journal:  Nutrients       Date:  2022-08-17       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.